Results 191 to 200 of about 73,761 (306)
DAOSD occurred in 34.6% of dupilumab‐treated paediatric AD patients, of which 30.6% required ocular anti‐inflammatory therapy. This high incidence rate underscores the importance of awareness during dupilumab treatment in paediatric patients. Elevated baseline serum IgE levels (≥ 3000 kU/L) may predict DAOSD development in paediatric AD patients ...
Lisa P. van der Rijst+6 more
wiley +1 more source
Inhibition of Tacrolimus Metabolism by Cannabidiol and Its Metabolites In Vitro. [PDF]
So GC+8 more
europepmc +1 more source
Abstract Objectives Reports of real‐world data concerning chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are limited in Japan. This study aimed to investigate the diagnostic testing and treatment performed in patients diagnosed with CIDP in Japan. Methods Using a Japanese commercial medical information database, we analyzed diagnostic
Motoi Kuwahara+5 more
wiley +1 more source
The effectiveness of remote interventions based on digital health technology in kidney transplant recipients: a systematic review. [PDF]
Kuang M, Yao Z, Chen J, Yan Y, Li Z.
europepmc +1 more source
Five-year experience with tacrolimus rescue for renal allograft rejection [PDF]
Mark L. Jordan+12 more
openalex +1 more source
Abstract Objectives IgPro20, a subcutaneous immunoglobulin replacement therapy, is approved in Japan for chronic inflammatory demyelinating polyneuropathy (CIDP). This post‐marketing surveillance study characterized real‐world treatment patterns and safety profile of injection site reactions associated with IgPro20 treatment in Japanese patients with ...
Naoki Terasaka+4 more
wiley +1 more source
Maintenance Immunosuppression in Kidney Transplantation: A Review of the Current Status and Future Directions. [PDF]
Khan MA+6 more
europepmc +1 more source
Tacrolimus can resolve cyclosporin-induced gingival hyperplasia [PDF]
Prakash Harikrishnan
openalex +1 more source
ABSTRACT Background To identify evidence on the use of topical CsA for ocular surface diseases (OSD). Methods A literature search was conducted following the preferred reporting items for systematic reviews and meta‐analyses (PRISMA) through June 2023 via Cochrane Central Registries, Clinical Trials Registry, Grey literature and citation searching ...
Ngozi C. Chidi‐Egboka+10 more
wiley +1 more source